Literature DB >> 25472673

Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry.

Barbara J Fuhrman1, Xia Xu2, Roni T Falk3, Cher M Dallal3, Timothy D Veenstra2, Larry K Keefer4, Barry I Graubard3, Louise A Brinton3, Regina G Ziegler3, Gretchen L Gierach3.   

Abstract

BACKGROUND: Interindividual differences in estrogen metabolism may partially account for differences in risks of estrogen-responsive cancers. We conducted a proof-of-performance study to assess the reproducibility of a LC/MS-MS method for measurement of 15 serum estrogens and metabolites (all 15 termed EM) in total (conjugated+unconjugated) and unconjugated forms and describe interindividual variation.
METHODS: Interindividual variation in serum EM profiles was evaluated for 20 premenopausal women, 15 postmenopausal women, and 10 men. Replicate aliquots from 10 premenopausal women, 5 postmenopausal women, and 5 men were assayed eight times over 4 weeks. Components of variance were used to calculate coefficients of variation (CV) and intraclass correlation coefficients (ICC).
RESULTS: In postmenopausal women and men, median EM concentrations were similar and substantially lower than that in premenopausal women. Within each sex/menopausal group, the sum of all EM varied 5- to 7-fold across extreme deciles. Some EM had greater variation; total estrone varied approximately 12-fold in premenopausal and postmenopausal women. Unconjugated estradiol varied 17-fold in postmenopausal women but only 5-fold in premenopausal women and men. CVs reflecting variation across replicate measures for individuals were <5% for most EM, but higher in some individuals with a low EM concentration. Overall laboratory CVs for all but one EM were <2% and ICCs were >99% for all EM in each group.
CONCLUSIONS: The serum EM assay has excellent laboratory reproducibility. In premenopausal women, postmenopausal women, and men, interindividual variation in EM measures is substantially greater than laboratory variation. IMPACT: The serum EM assay is suitable for epidemiologic application. See all the articles in this CEBP Focus section, "Biomarkers, Biospecimens, and New Technologies in Molecular Epidemiology." ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25472673      PMCID: PMC4289148          DOI: 10.1158/1055-9965.EPI-14-0438

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

Review 1.  Estrogen metabolism by conjugation.

Authors:  R Raftogianis; C Creveling; R Weinshilboum; J Weisz
Journal:  J Natl Cancer Inst Monogr       Date:  2000

Review 2.  Estrogen carcinogenesis in breast cancer.

Authors:  James D Yager; Nancy E Davidson
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

3.  Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.

Authors:  Bao Ting Zhu; Gui-Zhen Han; Joong-Youn Shim; Yujing Wen; Xiang-Rong Jiang
Journal:  Endocrinology       Date:  2006-05-25       Impact factor: 4.736

4.  Estrogen exposure during gestation and risk of testicular cancer.

Authors:  R H Depue; M C Pike; B E Henderson
Journal:  J Natl Cancer Inst       Date:  1983-12       Impact factor: 13.506

5.  Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.

Authors:  M H Gail; T R Fears; R N Hoover; D W Chandler; J L Donaldson; M B Hyer; D Pee; W V Ricker; P K Siiteri; F Z Stanczyk; J B Vaught; R G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-10       Impact factor: 4.254

Review 6.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations.

Authors:  E Cavalieri; K Frenkel; J G Liehr; E Rogan; D Roy
Journal:  J Natl Cancer Inst Monogr       Date:  2000

7.  Standardization of steroid hormone assays: why, how, and when?

Authors:  Frank Z Stanczyk; Jennifer S Lee; Richard J Santen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

Review 8.  Intracrinology of estrogens and androgens in breast carcinoma.

Authors:  Hironobu Sasano; Takashi Suzuki; Yasuhiro Miki; Takuya Moriya
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-06       Impact factor: 4.292

9.  Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry.

Authors:  Xia Xu; John M Roman; Haleem J Issaq; Larry K Keefer; Timothy D Veenstra; Regina G Ziegler
Journal:  Anal Chem       Date:  2007-09-12       Impact factor: 6.986

10.  Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study.

Authors:  Roni T Falk; Louise A Brinton; Joanne F Dorgan; Barbara J Fuhrman; Timothy D Veenstra; Xia Xu; Gretchen L Gierach
Journal:  Breast Cancer Res       Date:  2013-04-22       Impact factor: 6.466

View more
  12 in total

Review 1.  Epidemiologic studies of estrogen metabolism and breast cancer.

Authors:  Regina G Ziegler; Barbara J Fuhrman; Steven C Moore; Charles E Matthews
Journal:  Steroids       Date:  2015-02-26       Impact factor: 2.668

Review 2.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

3.  Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel.

Authors:  Wenzhen Ma; Xingjuan Chen; Rok Cerne; Samreen K Syed; James V Ficorilli; Over Cabrera; Alexander G Obukhov; Alexander M Efanov
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

4.  Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.

Authors:  Joshua N Sampson; Roni T Falk; Catherine Schairer; Steven C Moore; Barbara J Fuhrman; Cher M Dallal; Douglas C Bauer; Joanne F Dorgan; Xiao-Ou Shu; Wei Zheng; Louise A Brinton; Mitchell H Gail; Regina G Ziegler; Xia Xu; Robert N Hoover; Gretchen L Gierach
Journal:  Cancer Res       Date:  2016-12-23       Impact factor: 12.701

5.  Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study.

Authors:  Susan R Davis; Robin J Bell; Penelope J Robinson; David J Handelsman; Tom Gilbert; James Phung; Reena Desai; Jessica E Lockery; Robyn L Woods; Rory S Wolfe; Christopher M Reid; Mark R Nelson; Anne M Murray; John J McNeil
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 6.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Authors:  Bríd M Ryan; Jessica M Faupel-Badger
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

7.  Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Hannah Oh; Zeina G Khodr; Mark E Sherman; Maya Palakal; Ruth M Pfeiffer; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Roni T Falk; Hisani N Horne; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Xia Xu; Timothy Veenstra; Stephen M Hewitt; John A Shepherd; Louise A Brinton; Jonine D Figueroa; Gretchen L Gierach
Journal:  Horm Cancer       Date:  2016-05-02       Impact factor: 3.869

8.  Relationship of serum estrogens and metabolites with area and volume mammographic densities.

Authors:  Gretchen L Gierach; Deesha A Patel; Roni T Falk; Ruth M Pfeiffer; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; John A Shepherd; Amir Pasha Mahmoudzadeh; Jeff Wang; Bo Fan; Sally D Herschorn; Xia Xu; Timothy Veenstra; Barbara Fuhrman; Mark E Sherman; Louise A Brinton
Journal:  Horm Cancer       Date:  2015-03-11       Impact factor: 3.869

9.  Estrogen Metabolism in Postmenopausal Women Exposed In Utero to Diethylstilbestrol.

Authors:  Rebecca Troisi; Elizabeth E Hatch; Julie R Palmer; Linda Titus; Joshua N Sampson; Xia Xu; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-26       Impact factor: 4.254

10.  Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women.

Authors:  Gieira S Jones; Heather Spencer Feigelson; Roni T Falk; Xing Hua; Jacques Ravel; Guoqin Yu; Roberto Flores; Mitchell H Gail; Jianxin Shi; Xia Xu; James J Goedert
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.